▶ 調査レポート

医療・健康保険のイギリス市場2021-2026:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:United Kingdom Health and Medical Insurance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Mordor Intelligenceが調査・発行した産業分析レポートです。医療・健康保険のイギリス市場2021-2026:成長・動向・新型コロナの影響・市場予測 / United Kingdom Health and Medical Insurance Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) / MRC2108A572資料のイメージです。• レポートコード:MRC2108A572
• 出版社/出版日:Mordor Intelligence / 2021年7月
• レポート形態:英文、PDF、180ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:金融サービス
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Team User¥555,000 (USD3,750)▷ お問い合わせ
  Corporate License¥962,000 (USD6,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、医療・健康保険のイギリス市場規模が2021年から2026年の間に5.05%成長すると予測しています。本調査資料では、イギリスの医療・健康保険市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場インサイト・動向、製品種類別分析、種類別分析、競争状況、市場の将来などを掲載しています。

The health and medical insurance market is expected to register a healthy CAGR of 5.05%, during the forecast period (2021-2026). Market for private healthcare services projected to reach USD 13.8 Bn by 2025 due to rise in NHS waiting times and referrals to the private sector. Health cover has become the highest public priority. Healthcare is most frequently cited, by voters, as the most important aspect of government spending. The NHS has, thus, become a protected department, with the awareness of all political parties about NHS spending on the overall health coverage. According to the data published by the Association of British Insurers (ABI), 1.7 million people in the United Kingdom had private medical insurance (PMI). The NHS across the UK spent nearly £159 billion in 2018/19. This is equivalent to £2,300 for every person in the UK and represents 7.1% of UK GDP.

Healthcare UK also helps the NHS to fulfil its important role in international health development. Through the Prosperity Fund’s ‘Better Health Programme,’the UK is supporting 8 middle income countries to strengthen their health systems as they progress towards achieving universal health coverage.

Throughout the UK, there is a coexistence of public hospitals, private non-profit hospitals, and private for-profit hospitals. While hospitals are mainly publicly owned and independently operated, they are organized as hospital trusts with three hierarchical levels: community hospitals, district hospitals, and regional or inter-regional hospitals, as well as a number of specialized hospitals offering advanced treatment. In line with the EU average, health services are predominantly financed from general taxation.

The industry currently boasts total annual turnover of over £70 billion. Around £30 billion of this is made up from exports, meaning the demand for an international supply of British life science goods and services continues to thrive. Health businesses who choose Britain for their life sciences ventures will find they have access to a wide spread of financial opportunities through the City of London and venture capital community.

Key Market Trends

PMI Gaining Huge Market amid the Uncertainties Surrounding Brexit

Private Medical Insurance – medical cover subscribers comprise of 11% of the population. Total spending on the UK private medical cover, which includes insured and self-insured healthcare trusts, grew by 2.8% in 2015. Unlike other countries where the govt and private providers see one other as competitors, the Health care in UK is free and its mostly compensated by the taxpayer. In UK, the Public-Private health care complement one another. Consumers generally opt for private health care only if they need specific conditions or rare conditions that might not be included in the public health care program.

Significant developments in premiums belie the underlying trends in demand. Factors driving the apparent shift in attitudes include improved levels of satisfaction with NHS, increased public healthcare spending, and deterioration in labor market conditions. The consumer shift away from private medical insurance is unlikely to be fully reversed.

A recent economic recovery may improve wage and employment conditions wherein NHS reforms are expected to push for the role of the private healthcare and insurance sector, while UK’s evolving demographic profile may increase the strain on the public healthcare system.

The current volatile economic scenario does not prescribe continued growth in the category. However, the demand for lower-cost policy coverage has propelled growth in the popularity and availability of cheaper healthcare cash plans, and self-pay options for one-off treatments.

Spotlight on the Employee Sponsored Health Coverage in the United Kingdom

NHS has always ensured that the United Kingdom maintains an extensive social security system. The UK economy has a problem due to its present political crisis. However, it possesses a robust economic growth, with low inflation and lower unemployment rates as huge plus. Employers consider health and wellness as a prime objective in providing health benefits to their employees. In the United Kingdom, up to 45% of the employers aim to include health and well-being of employees in their company goals, within three years of the formation of the company. With rising income producing employers and growth in the awareness of the extensive health coverage offered, this segment is expected to exhibit prominent growth during the forecast period.

UK employees receive fundamental health and retirement coverage via government programs, and gain wide access to a well-established financial services industry, which offers consumers a broad set of choices in private health care, insurance, and investment products. Due to the availability of these resources, workers in the United Kingdom express far less concern than US employees, regarding financial issues ranging from having enough money to live on (44% of UK employees, as compared to 59% in the US), to being able to afford relevant health insurance for self and one’s family (28% in the United Kingdom and 57% in the United States).

Competitive Landscape

In spite of being a concentrated market, lack of competition among private hospitals has constrained insurers the bargaining power, thereby, resulting in inflated claims costs. Coupled with the reduction in customer numbers, this has been the biggest driver for premium growth, as insurers responded to the burden on profitability by raising prices for customers.

The consumer shift away from private medical insurance is unlikely to be fully reversed. Favorable forces may support a modest CAGR of 2% for gross written premiums, over the forecast period (2013–2017).

A recent recovery in economic growth may improve wage and employment conditions in the United Kingdom. Also, NHS reforms are expected to advance the role of private healthcare in the insurance sector. On the other hand, UK’s evolving demographic profile may increase the strain on the public healthcare system.

Bupa continues be the market leader in the UK health and medical insurance market, holding more than 50% of the market share. Its annual revenue from the health insurance business segment accounted for more than 80%, in 2017.

The market concentration is ‘high’, as it is dominated by four companies, namely, BUPA, Axa PPP, Aviva, and Prudential, which contributed a cumulative market share of greater than 90%, in 2016.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY
2.1 Study Deliverables
2.2 Study Assumptions
2.3 Analysis Methodology
2.4 Research Phases

3 EXECUTIVE SUMMARY

4 GOVERNMENT REGULATIONS AND INITIATIVES
4.1 Brief on the Health Insurance Industry Regulation in the United Kingdom – Role of NHS UK in the Healthcare Delivery
4.2 Insights on Latest Healthcare Policy Changes and their Effect on the Overall Health Spending in the United Kingdom
4.3 Effect of Brexit on Health Insurance Coverage in the United Kingdom
4.4 Insights on UK Social Health Insurance (SHI) and its Impact on the Overall Health Coverage of UK Citizens and the Preference for Private Medical Insurance (PHI) over SHI

5 MARKET INSIGHTS AND DYNAMICS
5.1 Current Market Scenario
5.2 Brief on Health Insurance Premiums and Study on the Effect of Medical Trend Rate on Health Plans
5.3 Market Dynamics
5.3.1 Drivers
5.3.2 Restraints
5.3.3 Opportunities
5.4 Insights on the Technical Advancements that are Shaping up the Future of Health Insurance Industry in the United Kingdom
5.5 Industry Attractiveness – Porters Five Forces Analysis
5.5.1 Threat of New Entrants
5.5.2 Bargaining Power of Buyers/Consumers
5.5.3 Bargaining Power of Suppliers
5.5.4 Threat of Substitute Products
5.5.5 Intensity of Competitive Rivalry
5.6 Imapct of Covid-19 on the UK health and medical insurance market

6 MARKET SEGMENTATION
6.1 By Product Type
6.1.1 Private Medical Insurance
6.1.1.1 Individual Policy Coverage
6.1.1.2 Group Policy Coverage
6.1.2 Healthcare Cash Plans
6.1.2.1 Individual Policy Coverage
6.1.2.2 Group Policy Coverage
6.1.3 Dental Insurance Plans
6.1.3.1 Individual Policy Coverage
6.1.3.2 Group Policy Coverage
6.2 By Procurement type
6.2.1 Self-Pay Health Coverage
6.2.2 Employee Sponsored Health Coverage

7 COMPETITIVE LANDSCAPE
7.1 Overview (Market Concentration and Major Players)
7.2 Company Profiles
7.2.1 BUPA
7.2.2 AXA PPP
7.2.3 PT Astra Aviva Life
7.2.4 Freedom Health Insurance
7.2.5 Cigna Life Insuance Company Of Europe SA-NV
7.2.6 Simplyhealth Group Ltd
7.2.7 WPA – Western Provident Association
7.2.8 Vitality Health
7.2.9 Other Key Players

8 FUTURE GROWTH PROSPECTS OF THE MARKET

9 DISCLAIMER